Royalty Pharma PLC (RPRX)
NASDAQ
News
Market Data
Register for real-time alerts, custom portfolio, and market movers
| Quarter End | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | ||||
| Total Revenue | 589.7M | 617.71M | 467.76M | 683.97M | 653.4M | 543.61M | 473.57M | 567.98M |
| Operating Income | 432.27M | 233.2M | 28.33M | 513.58M | 363.27M | 153.52M | 468.93M | -87.92M |
| Pre Tax Income | 491.6M | 220.41M | -610.03M | 509.09M | 351.34M | 122.08M | 717.59M | -4.27M |
| Net Income | 304.5M | 142.65M | -456.08M | 340.76M | 227.63M | 72.11M | 494.34M | 4.78M |
| Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Basic Earnings Per Share (EPS) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBIT | 456.87M | 238.37M | -3.71M | 535.06M | 372.24M | 155.06M | 754.91M | 36.23M |
| EBITDA | 432.27M | 233.2M | 28.33M | 513.58M | 363.27M | 153.52M | 468.93M | -87.92M |
| Year End December 30 2023 | 2020 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 2.12B | 2.29B | 2.24B | 2.35B |
| Operating Income | -13.79M | 1.64B | 1.41B | 913.92M | 1.5B |
| Pre Tax Income | 51.28M | 1.7B | 1.24B | 230.06M | 1.7B |
| Net Income | 51.28M | 975.04M | 619.73M | 42.83M | 1.13B |
| Preferred Dividends | 0 | 0 | 0 | 0 | 0 |
| Basic Earnings Per Share (EPS) | 0.14 | 0.756 | 0.464 | 0.032 | 0.842 |
| EBIT | -13.79M | 1.87B | 1.38B | 858.91M | 1.82B |
| EBITDA | -13.79M | 1.66B | 1.43B | 919.59M | 1.5B |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
